Phase 2 results of the Nash trial and new Partner Deal still on track to be released this quarter according to Gary in this new interview ..STRONG BUY before the news hit the wire
https://unauthorised investment advice/health/health-kick-podcast-developing-drugs-fighting-fibrosis-and-squeezing-squishometers/
Meanwhile, Pharmaxis (ASXXS) has developed a treatment for cystic fibrosis called Bronchitol, which is approved in Europe and subject to US approval.The company is also eyeing treatments for a common liver disease called NASH – non alcoholic steatohepatitis, or ‘fatty liver disease’ – as well as diabetic retinopathy and the fatal lung disease idiopathic pulmonary fibrosis.So tune in to hear the pair discuss developing drugs, fighting fibrosis and squeezing squishometers
PXS=MC $75 M --2 Marketed Products --MEGA Milestones IMMINENT =Disallowed or Buyout Gem, page-8
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.002(6.06%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.3¢ | 3.1¢ | $2.321K | 72.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 246764 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 189544 | 2 |
View Market Depth
| Last trade - 11.22am 18/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |